ArticleBMC genomics2025
Integrative analysis of Hub1 overexpression: driving transcriptional reprogramming and alternative splicing in Saccharomyces cerevisiae.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transcriptomic Analysis Reveals HowLife (Basel, Switzerland) · 2026Article
- Genome-wide Association Study Reveals Novel Growth-related SNPs and Candidate Genes in Grass Carp (Ctenopharyngodon idella) Adapted to Hyper-salinity Stress.Marine biotechnology (New York, N.Y.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHub1, a conserved ubiquitin-like protein, is essential for pre-mRNA splicing and transcriptional regulation in Saccharomyces cerevisiae. Despite its known functions, the genome-wide effects of Hub1 overexpression remain largely uncharacterized. This study investigates the transcriptomic and splicing landscape changes triggered by Hub1 overexpression using an integrative bioinformatic approach.
resultsWe analyzed RNA-seq data from the GSE84215 dataset, employing differential expression, alternative splicing, functional enrichment, and network-based methods. DESeq2 identified 3,915 differentially expressed genes (DEGs; 1,964 upregulated, 1,951 downregulated, padj < 0.05), demonstrating extensive transcriptional reprogramming. Principal component analysis revealed that Hub1 overexpression explained 98% of transcriptional variance, indicating its dominant regulatory influence. Using rMATS, we detected seven exon skipping events, with DYN2 showing significant differential splicing (FDR = 0.0481, ΔPSI = - 0.036). MaxEntScan analysis confirmed that DYN2's 5' splice site is significantly weaker than canonical yeast splice sites (score = - 18.32, p = 0.03), consistent with Hub1's role in facilitating non-consensus splicing. Functional enrichment analyses revealed metabolic reprogramming, with upregulated pathways including biosynthesis of secondary metabolites and carbon metabolism, while growth-related processes like ribosome biogenesis and cell cycle were downregulated. Gene Set Enrichment Analysis (GSEA) further supported stress response activation (p53 signaling, NES = 1.255) and cell cycle suppression (NES = - 0.692). Weighted Gene Co-expression Network Analysis (WGCNA) identified 61 co-expression modules, with the brown module highly correlated with Hub1 overexpression (r = 0.99, p < 0.001) and enriched in biosynthetic and proteasome pathways. Protein-protein interaction network analysis revealed 35 Hub1 interactors, including spliceosomal components, reinforcing its central role in RNA processing.
conclusionOur findings reveal that Hub1 overexpression drives coordinated transcriptional and post-transcriptional changes, promoting metabolic reprogramming while specifically modulating splicing of genes with weak splice sites like DYN2. These results establish Hub1 as a dual regulator linking transcriptional control with splicing precision, suggesting a regulatory mechanism that enhances cellular adaptability under stress conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.